Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Biochemical and Biophysical Research Communications
|
December 10, 2014
Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells
Jen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 6, 2013
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells
Ruey-Shyang Chen, Jen-Chung Ko, Hsien-Chun Chiu, et al.
Cancer Research
|
August 21, 2020
Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer Dissemination
Ming-Han Kuo, An-Chun Lee, Shih-Hsin Hsiao, et al.
Biochemical Pharmacology
|
August 12, 2022
Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells
Jen-Chung Ko, Jyh-Cheng Chen, Jou-Min Hsieh, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 17, 2012
HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
Jen-Chung Ko, Huang-Jen Chen, Yu-Ching Huang, et al.
Pharmacology
|
November 9, 2021
Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells
Jen-Chung Ko, Jyh-Cheng Chen, Chia-Li Wei, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2013
Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells
Jen-Chung Ko, Hsien-Chun Chiu, Ting-Yu Wo, et al.
Cancer Medicine
|
August 10, 2023
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients
Sheng-Kai Liang, Chang-Wei Wu, Ching-I Chang, et al.
American Journal of Cancer Research
|
August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)
Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
Cancers
|
April 3, 2021
Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer
Ping-Hsien Tsou, Zong-Lin Lin, Yu-Chiang Pan, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Biochemical and Biophysical Research Communications
|
December 10, 2014
Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells
Jen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 6, 2013
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells
Ruey-Shyang Chen, Jen-Chung Ko, Hsien-Chun Chiu, et al.
Cancer Research
|
August 21, 2020
Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer Dissemination
Ming-Han Kuo, An-Chun Lee, Shih-Hsin Hsiao, et al.
Biochemical Pharmacology
|
August 12, 2022
Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells
Jen-Chung Ko, Jyh-Cheng Chen, Jou-Min Hsieh, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 17, 2012
HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
Jen-Chung Ko, Huang-Jen Chen, Yu-Ching Huang, et al.
Pharmacology
|
November 9, 2021
Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells
Jen-Chung Ko, Jyh-Cheng Chen, Chia-Li Wei, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2013
Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells
Jen-Chung Ko, Hsien-Chun Chiu, Ting-Yu Wo, et al.
Cancer Medicine
|
August 10, 2023
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients
Sheng-Kai Liang, Chang-Wei Wu, Ching-I Chang, et al.
American Journal of Cancer Research
|
August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)
Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
Cancers
|
April 3, 2021
Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer
Ping-Hsien Tsou, Zong-Lin Lin, Yu-Chiang Pan, et al.
Page
of 6